Published on 9 May 2024 on Simply Wall St. via Yahoo Finance
Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts...
Last week, you might have seen that Aquestive Therapeutics, Inc. (NASDAQ:AQST) released its first-quarter result to the market. The early response was not positive, with shares down 5.9% to US$3.09 in the past week. Revenues were in line with expectations, at US$12m, while statutory losses ballooned to US$0.17 per share. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Aquestive Therapeutics after the latest results.
See our latest analysis for Aquestive Therapeutics
